Custom Ultrasonics to Recall all of its Automated Endoscope Reprocessors

The Food and Drug Administration (FDA) has ordered Custom Ultrasonics to recall all of its automated endoscope reprocessors (AERs) from healthcare facilities due to the firm’s continued violations of federal law. The reason that the FDA has cracked down, is due to the increased risk of infection transmission. The FDA ordered this recall under the terms of the consent decree, as well as issued a safety communication recommending that healthcare facilities currently using Custom Ultrasonics AERs transition away from their use to alternative methods to reprocess flexible endoscopes as soon as possible.